Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives $4.00 Consensus PT from Analysts

Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) have received a consensus rating of “Hold” from the five brokerages that are currently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and one has assigned a buy recommendation to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $4.00.

BIOX has been the subject of several analyst reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Bioceres Crop Solutions in a research report on Monday, December 29th. Canaccord Genuity Group lowered their price target on Bioceres Crop Solutions from $2.25 to $2.00 and set a “hold” rating for the company in a report on Friday, January 2nd. Wall Street Zen raised shares of Bioceres Crop Solutions from a “sell” rating to a “hold” rating in a report on Saturday, November 22nd. Finally, Oppenheimer cut shares of Bioceres Crop Solutions from an “outperform” rating to a “market perform” rating in a report on Wednesday, October 22nd.

Bioceres Crop Solutions Stock Performance

NASDAQ:BIOX opened at $1.29 on Friday. Bioceres Crop Solutions has a 12 month low of $1.17 and a 12 month high of $7.44. The company has a debt-to-equity ratio of 0.19, a current ratio of 0.94 and a quick ratio of 0.64. The firm has a market capitalization of $81.56 million, a PE ratio of -1.54 and a beta of 0.47. The business’s fifty day moving average price is $1.49 and its 200 day moving average price is $2.23.

Hedge Funds Weigh In On Bioceres Crop Solutions

Several hedge funds have recently made changes to their positions in BIOX. Jones Financial Companies Lllp increased its position in shares of Bioceres Crop Solutions by 3,535.8% during the first quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock worth $25,000 after purchasing an additional 5,339 shares in the last quarter. Bank of America Corp DE grew its stake in Bioceres Crop Solutions by 186.8% during the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock worth $35,000 after buying an additional 3,735 shares during the last quarter. Avanza Fonder AB increased its position in Bioceres Crop Solutions by 62.9% during the second quarter. Avanza Fonder AB now owns 26,164 shares of the company’s stock worth $117,000 after buying an additional 10,099 shares during the period. PDT Partners LLC increased its position in Bioceres Crop Solutions by 58.9% during the second quarter. PDT Partners LLC now owns 28,180 shares of the company’s stock worth $126,000 after buying an additional 10,449 shares during the period. Finally, Virtu Financial LLC purchased a new stake in Bioceres Crop Solutions in the third quarter valued at approximately $40,000. Hedge funds and other institutional investors own 17.68% of the company’s stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp. is an agricultural biotechnology company focused on developing, manufacturing and commercializing a range of crop inputs designed to enhance yields and improve sustainability. The company’s portfolio includes biological seed treatments, inoculants for nitrogen fixation, specialty fertilizers and proprietary biopesticides, which are formulated to support plant health and resilience under varying environmental conditions.

Among its flagship offerings is the HB4 drought-tolerant wheat technology, the first genetically modified wheat developed to withstand water stress, which has received regulatory approval in several markets.